hackettg

MHRA Class 4 Medicines Defect Information: Oxybutynin hydrochloride 2.5 mg/5 ml Oral Solution (Brillpharma Limited) Drug alert number: EL (24)A/61 Date issued: 4 December 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Oxybutynin hydrochloride 2.5 mg/5 ml Oral Solution (Brillpharma Limited) DMRC reference number:DMRC-34033472 Company [...]

The post MHRA Class 4 Medicines Defect Information: Oxybutynin hydrochloride 2.5 mg/5 ml Oral Solution (Brillpharma Limited) appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Information: Mycophenolate Mofetil 1g/5ml Oral Suspension (Rosemont Pharmaceuticals Limited) Drug alert number: EL (24)A/59 Date issued: 2 December 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Mycophenolate Mofetil 1g/5ml Oral Suspension (Rosemont Pharmaceuticals Limited) DMRC reference number: DMRC-33616486 Company name: [...]

The post MHRA Class 4 Medicines Defect Information: Mycophenolate Mofetil 1g/5ml Oral Suspension (Rosemont Pharmaceuticals Limited) appeared first on Community Pharmacy England.

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 December 2024. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]

The post Drug Tariff Watch – December 2024 appeared first on Community Pharmacy England.

The NHS Business Services Authority (NHSBSA) produces a quarterly newsletter called “Hints & Tips for dispensing contractors”. The latest edition (Issue 57) contains some useful information and advice on: MYS July Activity: Tuesday 5 November 2024 deadline New ePACT2 dashboards: UTI and Pharmacy First 2024/25 seasonal flu vaccine reimbursement New oversupply data available in ePACT2 [...]

The post NHSBSA ‘Hints & Tips’ – Issue 57 appeared first on Community Pharmacy England.

Drug alert number: EL (24)A/44 Date issued: 30 September 2024 Pfizer Limited is recalling all distributed batches of Oxbryta 500 mg Tablets. Pfizer Limited has informed the MHRA that the product is being withdrawn due to emerging data from clinical trials and registry-based studies: Oxbryta (voxelotor) 500mg Tablets (Pfizer Limited) PLGB 00057/1720 DMRC Number: DMRC-32749585 [...]

The post MHRA Class 2 Medicines Recall: Oxbryta (voxelotor) 500mg Tablets (Pfizer Limited) appeared first on Community Pharmacy England.